The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial

Garcia-Manau P, Mendoza M, Bonacina E, Martin-Alonso R, Martin L, Palacios A, Sanchez ML, Lesmes C, Hurtado I, Perez E, Tubau A, Ibañez P, Alcoz M, Valiño N, Moreno E, Borrero C, Garcia E, Lopez-Quesada E, Diaz S, Broullon JR, Teixidor M, Chulilla C, Gil MM, Lopez M, Candela-Hidalgo A, Salinas-Amoros A, Moreno A, Morra F, Vaquerizo O, Soriano B, Fabre M, Gomez-Valencia E, Cuiña A, Alayon N, Sainz JA, Vives A, Esteve E, Ocaña V, López MÁ, Maroto A, Carreras E
The Fetal Growth Restriction at Term Managed by Angiogenic Factors Versus Feto-Maternal Doppler (GRAFD) Trial to Avoid Adverse Perinatal Outcomes: Protocol for a Multicenter, Open-Label, Randomized Controlled Trial
JMIR Res Protoc 2022;11(10):e37452
doi: 10.2196/37452 PMID: 36222789 PMCID: 9597418

Export Metadata

END for: Endnote

BibTeX for: BibDesk, LaTeX

RIS for: RefMan, Procite, Endnote, RefWorks

Add this article to your Mendeley library

This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (eHealth) (442) Obstetrics, Gynecology, and Reproductive Medicine (152) Pregnancy Information, Education and Lifestyle Interventions (234)

Download

Download PDF Download XML